PIM
AGIO icon

Platinum Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Platinum Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-56,593
Closed -$3.12M – 148
2021
Q2 		$3.12M Hold
56,593
– – 0.07% 80
2021
Q1 		$2.92M Sell
56,593
-12,159
-18% -$602K 0.07% 74
2020
Q4 		$2.98M Hold
68,752
– – 0.07% 72
2020
Q3 		$2.41M Hold
68,752
– – 0.06% 76
2020
Q2 		$3.68M Hold
68,752
– – 0.08% 59
2020
Q1 		$2.44M Buy
68,752
+7,318
+12% +$338K 0.06% 66
2019
Q4 		$2.93M Buy
61,434
+10,351
+20% +$391K 0.06% 55
2019
Q3 		$1.66M Buy
51,083
+13,647
+36% +$565K 0.04% 69
2019
Q2 		$1.87M Hold
37,436
– – 0.04% 63
2019
Q1 		$2.52M Hold
37,436
– – 0.06% 55
2018
Q4 		$1.73M Buy
37,436
+7,236
+24% +$447K 0.06% 53
2018
Q3 		$2.33M Hold
30,200
– – 0.07% 48
2018
Q2 		$2.54M Hold
30,200
– – 0.06% 46
2018
Q1 		$2.47M Sell
30,200
-5,600
-16% -$433K 0.07% 44
2017
Q4 		$2.05M Hold
35,800
– – 0.05% 54
2017
Q3 		$2.39M Hold
35,800
– – 0.06% 44
2017
Q2 		$1.84M Hold
35,800
– – 0.05% 48
2017
Q1 		$2.09M Hold
35,800
– – 0.06% 47
2016
Q4 		$1.49M Sell
35,800
-5,800
-14% -$304K 0.04% 53
2016
Q3 		$2.2M Buy
+41,600
New +$1.81M 0.05% 55

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Platinum Investment Management's AGIO Position: Q3 2021 in Review

Platinum Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2021, closing a stake of 56,593 shares — an estimated $3.12M sold.

Platinum Investment Management first reported a position in AGIO in Q3 2016 and held it in 20 quarters. The position peaked at $3.68M in Q2 2020. 165 funds tracked by Wall St. Rank hold AGIO as of Q3 2021.

  • Platinum Investment Management reported no remaining Agios Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Platinum Investment Management sold 56,593 Agios Pharmaceuticals shares in Q3 2021, an estimated $3.12M.
  • Platinum Investment Management first reported a position in Agios Pharmaceuticals in Q3 2016 and held it in 20 quarters.
  • Platinum Investment Management's Agios Pharmaceuticals position peaked at $3.68M in Q2 2020.
  • 165 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2021.

Based on Platinum Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.